| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 10/15/2002 | US6465188 Nucleic acid ligand complexes |
| 10/12/2002 | CA2381367A1 Method for purifying 5'-protected 2'-deoxypurine nucleosides |
| 10/10/2002 | WO2002079215A1 Building blocks for the solution phase synthesis of oligonucleotides |
| 10/10/2002 | WO2002079214A1 Preparation and isolation of indolocarbazole glycosides |
| 10/10/2002 | WO2002079213A1 Process for the preparation of 2'-halo-$g(b)-l-arabinofuranosyl nucleosides |
| 10/10/2002 | WO2002078747A2 Pregabalin lactose conjugates |
| 10/10/2002 | WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 10/10/2002 | US20020147332 Novel nucleoside and oligonucleotide analogues |
| 10/10/2002 | US20020147331 Methods for synthesis of oligonucleotides |
| 10/10/2002 | US20020147174 Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy |
| 10/10/2002 | US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/10/2002 | US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders |
| 10/10/2002 | US20020146787 Coenzymes useful for the synthesis of L-carnitine |
| 10/10/2002 | US20020146737 Nucleoside derivatives with photolabile protective groups |
| 10/10/2002 | US20020146726 Probes for use in the detection and measurement of preferential compound in sample |
| 10/10/2002 | CA2441214A1 Preparation and isolation of indolocarbazole glycosides |
| 10/09/2002 | EP1247524A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer |
| 10/09/2002 | EP0897301B1 Method of treating otitis media with uridine triphosphates and related compounds |
| 10/09/2002 | EP0827505B1 Selected soluble esters of hydroxyl-containing indolocarbazoles |
| 10/09/2002 | CN1373812A Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 10/09/2002 | CN1373768A Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use |
| 10/08/2002 | US6462191 Synthesis of 2-deoxy-2-fluoro-arabinose derivatives |
| 10/08/2002 | US6462184 Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds |
| 10/08/2002 | US6462183 Protected aminosugars |
| 10/08/2002 | US6462028 P2y2 and/or p2y4 purinergic receptor agonists e.g., nucleotides of adenosine, cytidine and uridine, dinucleotides and analogs; treating vaginal dryness associated with menopause, chemotherapy, and diseases; vulvar pain |
| 10/08/2002 | US6461863 Modifying insect cell gylcosylation pathways with baculovirus expression vectors |
| 10/03/2002 | WO2002077255A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 10/03/2002 | WO2002077002A2 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 10/03/2002 | WO2002076402A2 Fatty amine drug conjugates |
| 10/03/2002 | WO2002076400A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease |
| 10/03/2002 | WO2002030942A3 Anhydro sugar derivatives of indolocarbazoles |
| 10/03/2002 | WO2002030941A3 Topoisomerase inhibitors |
| 10/03/2002 | US20020143194 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| 10/03/2002 | US20020142994 Bisphosphonate conjugates and methods of making and using the same |
| 10/03/2002 | US20020142329 Electophoretic separation and detection of preferential particles; obtain samle, incubate with luminescent particle, apply charge, monitor migration of particle |
| 10/03/2002 | US20020142307 Preferential deprotection of a 3',5'-di-O- levulinyl nucleoside; obtain 3',5'-di-O- levulinyl nucleoside, incubate with lipase, recover 3'-O-levulinyl and 5'-O-levulinyl nucleoside |
| 10/03/2002 | CA2692295A1 Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer |
| 10/03/2002 | CA2441806A1 Inosine compounds and their use for treating or preventing an inflammation or a reperfusion disease |
| 10/03/2002 | CA2441412A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 10/02/2002 | EP1244667A2 Cyclohexene nucleic acids |
| 10/02/2002 | EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 10/02/2002 | EP0984976B1 Process for the preparation of a deoxyuridine derivative |
| 10/02/2002 | EP0853628B1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use |
| 10/02/2002 | EP0842181B1 Membrane-permeant second messengers |
| 10/02/2002 | DE10111681A1 Verbessertes Verfahren zur Herstellung von Pentopyranosyl-Nucleosiden An improved process for the preparation of pentopyranosylnucleosides |
| 10/02/2002 | CN1372564A Process for selectively producing 1-phosphorylated sugar deriative anomer and process for producing nucleoside |
| 10/01/2002 | US6458946 Crystals of diuridine tetraphosphate or salt thereof, process for producing the crystals, and process for producing the compounds |
| 10/01/2002 | US6458945 Detecting variance in nucleotide sequence; mixing adenosine-cytosine-, thymidine-, or uridine triphosphate with nucleotide in presence of polymerase |
| 10/01/2002 | US6458773 Nucleoside with anti-hepatitis B virus activity |
| 10/01/2002 | US6458772 Prodrugs |
| 09/26/2002 | WO2002074911A2 Identification of gene expression alterations underlying the aging process in mammals |
| 09/26/2002 | WO2002074910A2 Selective anti-viral nucleoside chain terminators |
| 09/26/2002 | WO2002074781A1 Process for preparing n6-substituted aminopurine ribofuranose nucleosides |
| 09/26/2002 | WO2002074780A1 Chemical compounds |
| 09/26/2002 | US20020137921 Oligonucleotides having chiral phosphorus linkages |
| 09/26/2002 | US20020137721 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 09/26/2002 | US20020137696 Specific modulation of TH1/TH2 cytokine expression by ribavirin in activated T-lymphocytes |
| 09/26/2002 | US20020137695 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels |
| 09/26/2002 | US20020137096 Solid phase synthesis; photolithography |
| 09/26/2002 | CA2441202A1 Chemical compounds |
| 09/26/2002 | CA2441086A1 Identification of gene expression alterations underlying the aging process in mammals |
| 09/25/2002 | EP1242438A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 09/25/2002 | EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 09/25/2002 | EP1175432A4 Processes for the synthesis of oligomers using phosphoramidite compositions |
| 09/25/2002 | EP0912613B1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 09/25/2002 | EP0841344B1 1-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)cytosines |
| 09/25/2002 | CN1371379A New indolocarbazole alkaloids from marine actinomycete |
| 09/24/2002 | US6455694 Antibiotics RK-1061 and process for preparing the same |
| 09/24/2002 | US6455690 L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine |
| 09/24/2002 | US6455682 Polyamide compound for use in determining the sequence of a target polynucleotide |
| 09/24/2002 | US6455513 Chemical compounds |
| 09/24/2002 | US6455510 Chemical Compounds |
| 09/24/2002 | US6455508 Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
| 09/24/2002 | US6455507 Benzimidazole derivatives |
| 09/24/2002 | US6455506 Lyxofuranosyl benzimidazoles as antiviral agents |
| 09/24/2002 | CA2105487C Antiviral nucleoside combination |
| 09/19/2002 | WO2002073201A1 Reagents for labeling protein |
| 09/19/2002 | WO2002072869A2 Novel agents for replacement of nad+/nadh system in enzymatic ractions |
| 09/19/2002 | WO2002072791A2 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
| 09/19/2002 | WO2002072779A2 Nucleic acid labeling compounds |
| 09/19/2002 | WO2002072595A2 Method for the production of pentopyranosyl nucleosides |
| 09/19/2002 | US20020132783 E.g., beta-1'-nicotinamide-2'-deoxyribose, beta-D-1'-nicotinamide-2'-deoxyribofuranoside, beta -1'-pyridyl-2'-deoxyribose, or 5'-phospho-1'-pyridyl-deoxyribose. |
| 09/19/2002 | CA2443557A1 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
| 09/19/2002 | CA2440615A1 Nucleic acid labeling compounds |
| 09/18/2002 | EP1241176A1 Purine derivatives for the treatment of ischemia |
| 09/18/2002 | EP1240922A2 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 09/18/2002 | EP1240899A2 Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections |
| 09/18/2002 | EP1239864A1 Treatment of heart rhythm disturbances with n6 -substituted-5'-(n-substituted) carboxamidoadenosines |
| 09/18/2002 | EP1212339A4 2'-o-acetamido modified monomers and oligomers |
| 09/18/2002 | CN1370171A Process for preparing inhibitors of nucleoside metabolism |
| 09/18/2002 | CN1370170A DNA methyltransferase inhibitors |
| 09/17/2002 | US6451540 2′-O-alkylthioalkyl and 2′-C-alkythioalkyl containing nucleic acids |
| 09/17/2002 | US6451536 Products for detecting nucleic acids |
| 09/17/2002 | US6451288 Method of treating lung diseases with uridine 5′-diphosphate and analogs thereof |
| 09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
| 09/17/2002 | CA2145405C Nucleotides labelled with an infrared dye and their use in nucleic acid detection |
| 09/17/2002 | CA2122036C Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 09/17/2002 | CA2116674C Imidazolidyl macrolides |
| 09/17/2002 | CA2020431C Aqueous liquid eyedrop composition |
| 09/17/2002 | CA2014662C Anti-virals |